Gushken A K F, Castro A P M, Yonamine G H, Corradi G A, Pastorino A C, Jacob C M A
Allergy and Immunology Unit, Department of Pediatrics, Instituto da Criança, Hospital das Clínicas da Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.
Allergol Immunopathol (Madr). 2013 Mar-Apr;41(2):94-101. doi: 10.1016/j.aller.2011.12.002. Epub 2012 Feb 10.
A double-blind, placebo-controlled food challenge (DBPCFC) is considered the gold standard for diagnosing food allergy, but because of methodological difficulties it is rarely conducted in clinical practice, especially in paediatric patients. The purpose of the study was to propose a DBPCFC protocol that is adapted to our conditions for the diagnosis of an IgE-mediated cow's milk allergy (CMA) in a Brazilian reference centre for paediatric allergies.
This study includes the experimental phase (choice of materials, adjustments made to protocols described in the literature) and the test execution phase. DBPCFCs were performed in 58 patients aged 1-15 years who were separated into two groups: Group 1 (n=39), sex 1.6 M:F, 5.3 years median age, suggestive history of IgE-mediated CMA; and Group 2 (n=19), sex 1.4 M:F, 8.3 years median age with symptoms not associated with milk ingestion and laboratory data not compatible with IgE-mediated CMA.
The materials were standardised for testing: containers and disposable products, low-lactose cow's milk (CM) and vehicles, such as natural fruit juice, vegetable soup and soybean-based beverages. Each DBPCFC was performed in a single day with two blind, randomised phases with a 2-h interval between them. The milk doses were gradually increased and offered in regular intervals of 15-30 min. Following negative or inconclusive results, patients underwent an open oral challenge test with 200 mL of low-lactose CM.
The proposed adaptation for the DBPCFC allowed to implement this important test for the diagnosis of IgE-mediated CMA in a reference centre for paediatric allergies. It was considered feasible and safe if performed in an appropriate setting with physician supervision.
双盲、安慰剂对照食物激发试验(DBPCFC)被认为是诊断食物过敏的金标准,但由于方法上的困难,它在临床实践中很少进行,尤其是在儿科患者中。本研究的目的是提出一种适合我们条件的DBPCFC方案,用于在巴西儿科过敏参考中心诊断IgE介导的牛奶过敏(CMA)。
本研究包括实验阶段(材料选择、对文献中描述的方案进行调整)和测试执行阶段。对58名1至15岁的患者进行了DBPCFC,这些患者被分为两组:第1组(n = 39),男女比例为1.6:1,中位年龄5.三岁,有IgE介导的CMA的提示性病史;第2组(n = 19),男女比例为1.4:1,中位年龄8.三岁,症状与摄入牛奶无关,实验室数据与IgE介导的CMA不相符。
测试材料进行了标准化:容器和一次性产品、低乳糖牛奶(CM)以及载体,如天然果汁、蔬菜汤和大豆基饮料。每次DBPCFC均在一天内进行,分为两个盲法、随机阶段,中间间隔2小时。牛奶剂量逐渐增加,每隔15 - 30分钟定期提供。在结果为阴性或不确定后,患者接受了200毫升低乳糖CM的开放性口服激发试验。
所提出的DBPCFC适应性方案使得在儿科过敏参考中心能够实施这项用于诊断IgE介导的CMA 的重要试验。如果在医生监督的适当环境中进行,该方案被认为是可行且安全的。